ACEM Primary Examination Pharmacology VIVA by YEAR

Note: Years with ** have been updated and include model answers as per FACEM I spreadsheet

Sitting	Station 1	Station 2	Station 3	Station 4	Station 5
** 2010.2	Potency and Efficacy	GTN	Pancuronium	Lithium	Eye Ointment
	Drug administration Routes	ACE Inhibitors	Erythromycin	Phenytoin	Benzodiazepine
	Total Body Clearance	Frusemide	Cephalosporins	Antipsychotic drugs	Flumazenil
** 2010.1	Spare receptors	Antibiotics in urinary sepsis	Aspirin	Amiodarone	Passive immunisation
	Antagonists / Agonists	Antibiotics in CNS infections	Paracetamol toxicity	Metoprolol	Drugs and clinical trials
	Second messengers	Drugs in status epilepticus	Morphine	Atropine	Therapeutic drug monitoring
** 2009.2	Drug biotransformation	Drugs in acute asthma	Propofol	tPA	Activated charcoal
	Dose response	Drugs used in diabetes	Ketamine	Warfarin	Amphetamines
	Drug clearance	NSAID	Suxamethonium	Calcium channel blockers	Topical anaesthetics
2009.1	Volume of Distribution	Adrenaline	Carbamazepine	Macrolides	Prescribing in the Elderly
	Drug Half Life	Digoxin	Chlorpromazine	Antibiotics: Staphylococcus	Prescribing in Pregnancy
	Zero + First Order Kinetics	Classes of Anti-hypertensives	Ondansetron	Acyclovir	Prescribing in Children
** 2008.2	First pass effect	Metronidazole	Tricyclic Antidepressants	Sulfonylureas	Laxatives
	Efficacy and Potency	Cephalosporins	SSRIs	Salbutamol	Thioamides
	P450 Enzyme System	Gentamicin	Phenytoin	Metaclopramide	Flecainide
** 2008.1	Second messengers	Angiotensin II blockers	LMW heparins	Atropine	Octreotide
	Competitive vs irreversible antagonists	Loop Diuretics	Fluoroquinolones	Thiopentone	Methylxantines
	Bioavailability	Nitrates	beta Lactams	Antiemetics	Biogenic amines
2007.2	Routes of drug administration	Beta 2 Agonists	Paracetamol	Agents for Gout	Over the counter preparations
	First pass effect	H1-blockers	Morphine	Levodopa	Penicillamine
	P450 enzyme system	Clonazepam	Aspirin	Acetazolamide	Dantrolene
** 2007.1	Volume of distribution	GTN	Gentamicin	tPA	Erythropoietin
	Efficacy & potency	beta Blockers	Midazolam	Osmotic diuretics	Olanzapine
	Phase I and Phase II reactions	Atropine	Prilocaine	Chloromycetin	Chlorhexidine
** 2006.2	Dose – Response	Calcium Channel Blockers	Ondansetron	Penicillin	St John’s Wort
	Second Messenger	Thiazide diuretics	Dexamethasone	Clopidogrel	Benztropine
	Drug Half Life	Class I Antiarrhythmics	Ketamine	Trimethoprim	Pharmacokinetics Elderly
2006.1	Efficacy and potency	Digoxin	Salicylate toxicity	Inhaled Asthma preventers	Vitamin K
	Volume of distribution	beta Blockers	Suxamethonium	Warfarin	Olanzapine
	Elimination kinetics	Heparins	Amiodarone	Nitrous oxide	Topical anaesthetics
2005.2	Absorption of drugs	Angiotensin II antagonists	Anti seizure drugs	Anti migraine agents	Glucagon
	Drug metabolism	Sympathomimetic agents	Opioids	Antibiotic resistance	Lithium
	Biotransformation	Adenosine	Benzodiazepines	Paracetamol	Laxatives
2005.1	Efficacy and potency	Valproate	Beta Blockers	Penicillin	Nitric acid
	Variation in drug response	Antipsychotic agents	Antiplatelet agents	Azithromycin	Antiemetics
	Bioavailability	Methanol	Lignocaine	Sulphonamides	COX2 inhibitors
2004.2	Second messenger	Nitrates	Midazolam	H1 receptor antagonists	Local anaesthetics
	Evaluation of new drugs	Loop diuretics	Digoxin toxicity	Cephalosporins	Insulin
	Prescribing in the Elderly	Beta Blockers	Lignocaine	Quinolones	Paracetamol
2004.1	Variation in drug response	Cardiac glycosides	H2 receptor antagonists	MAOI inhibitors	Tetracyclines
	First pass effect	Amiodarone	Opioids	SSRIs	Quinolones
** 2003.2	Second messengers	Gentamycin	Indirect cholinomimetics	Cyclooxygenase inhibitors	Glucagon
	Agonists/partial agonists	Tetracyclines	Beta receptor agonists	Aspirin	Oral hypoglycaemic agents
	Bioavailibility	Penicillin	Muscarinic blockers	Antiplatelet agents	Hydrocortisone
** 2003.1	Volume of distribution	ACE inhibitors	Propofol	Tetracyclines	Oral hypoglycaemic agents
	Biotransformation	Adenosine	Succinylcholine	Quinolones	Heparins